Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
13.32
+0.09 (0.68%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Surgery Partners Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Surgery Partners stock has a consensus rating of "Buy" and an average price target of $18.82. The average 1-year stock price forecast is 41.29% higher than the current stock price, while the lowest is $14 (+5.11%) and the highest is $24 (+80.18%).
Price Target: $18.82 (+41.29%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Surgery Partners stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $19 | Buy | Maintains | $19 | +42.64% | Sep 30, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $20 | Buy | Reiterates | $20 | +50.15% | Sep 18, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $19 | Buy | Reiterates | $19 | +42.64% | Sep 18, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Reiterates $14 → $15 | Hold | Reiterates | $14 → $15 | +12.61% | Sep 14, 2026 |
| Barclays | Barclays | Hold Maintains $14 | Hold | Maintains | $14 | +5.11% | Aug 28, 2026 |
Financial Forecast
Revenue This Year
3.15B
from 3.31B
Decreased by -4.88%
Revenue Next Year
2.81B
from 3.15B
Decreased by -10.73%
EPS This Year
0.35
from 0.47
Decreased by -25.53%
EPS Next Year
0.28
from 0.35
Decreased by -20.00%
EPS and Forward PE are based on non-GAAP adjusted numbers.